ORIGINAL RESEARCH article

Front. Oncol.

Sec. Gastrointestinal Cancers: Colorectal Cancer

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1562698

This article is part of the Research TopicMolecular Epigenetic Mechanisms in Early-Onset Colorectal CancerView all articles

Real-world analysis of community colorectal neoplasia screening based on stool DNA methylation detection

Provisionally accepted
FU  MingshengFU Mingsheng1*Shu-xian  PanShu-xian Pan1Xun-quan  CaiXun-quan Cai1Ya-wen  CaoYa-wen Cao1Li-yuan  JinLi-yuan Jin2Qin-cong  PanQin-cong Pan1
  • 1Shanghai Fifth People's Hospital, Fudan University, Shanghai, China
  • 2Maqiao Community Health Service Center, Shanghai, Shanghai Municipality, China

The final, formatted version of the article will be published soon.

This study aimed to assess the effectiveness of stool DNA methylation detection (sDNAMD) in improving colorectal neoplasia (CN) detection rates and colonoscopy compliance in a real-world community setting. Between July 1, 2023, and June 30, 2024, residents aged 50-75 from Maqiao Town, Minhang District, Shanghai, were invited to participate in a CN screening program. Participants were randomly assigned to one of three groups: high-risk questionnaire + fecal occult blood test (HRFO), high-risk questionnaire + FOBT + sDNAMD (HRFOsD), or sDNAMD only (sDNA). Colonoscopy was performed based on initial screening results, and the number of individuals undergoing colonoscopy, along with results, were recorded to calculate compliance and CN detection rates.The HRFOsD group exhibited a significantly higher colonoscopy compliance rate (93.7%) compared to the HRFO (32.6%) and sDNA (73.5%) groups (P<0.0001). Residents with negative FOBT, negative sDNA results, or those who did not undergo sDNA testing did not undergo colonoscopy. In the HRFOsD group, the CN detection rate was higher in females compared to males. Compared to the HR and FOBT+ group, the CN detection rate was significantly higher in the LR and FOBT+ and sDNA+ group. Adding sDNAMD to the high-risk questionnaire and FOBT screening led to a notable increase in both colonoscopy compliance and CN detection rates.The conclusion is that adding stool DNA methylation detection to the community FOBT screening program can significantly improve colonoscopy compliance and colorectal neoplasia detection rates among community residents.

Keywords: Colorectal neoplasia, stool DNA methylation detection, fecal occult blood testing, screening, colorectal cancer

Received: 18 Jan 2025; Accepted: 23 May 2025.

Copyright: © 2025 Mingsheng, Pan, Cai, Cao, Jin and Pan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: FU Mingsheng, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.